News & Announcements
-
IB Expands Distribution with Blackford
/**/ RNS Number : 5554V IQ-AI Limited 03 February 2025 February 3, 2025 Imaging Biometrics Expands Distribution with Blackford Imaging Biometrics, LLC (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), has amended their existing distribution agreement with AI platform provider Blackford Analysis Ltd (Blackford). The amendment adds
-
Operations Update
/**/ RNS Number : 1961U IQ-AI Limited 22 January 2025 IQ-AI Ltd (“IQ-AI” or the “Company”) Operations Update IQ-AI is pleased to announce an operations update. In this update, we focus on the relevance of artificial intelligence (“AI”) to our business, describe ongoing product development utilising AI in 2025, and provide an
-
IB and Prism Secure First Installation
/**/ RNS Number : 8964S IQ-AI Limited 10 January 2025 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics and Prism Clinical Imaging Secure First Installation The combined technologies will enhance neurosurgical planning and treatment strategies Imaging Biometrics (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is pleased
-
Imaging Biometrics Expands Distribution
/**/ RNS Number : 8473M IQ-AI Limited 20 November 2024 November 20, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Expands Distribution Imaging Biometrics (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI) has renewed its distribution agreement with GE HealthCare. This agreement aims to expand the distribution
-
Board Changes
/**/ RNS Number : 8206M IQ-AI Limited 19 November 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Board Changes IQ-AI Appoints Renowned Brain Tumor Champion to Board of Directors IQ-AI Ltd (LSE: IQAI) is pleased to announce the appointment of Dr. Al Musella, MD, as a Non-Execuitve Director. Dr. Musella brings